Mitochondrial Disease and the Kidney With a Special Focus on CoQ10 Deficiency.
Ontology highlight
ABSTRACT: Mitochondrial cytopathies include a heterogeneous group of diseases that are characterized by impaired oxidative phosphorylation, leading to multi-organ involvement and progressive clinical deterioration. Most mitochondrial cytopathies that cause kidney symptoms are characterized by tubular defects, but glomerular, tubulointerstitial, and cystic diseases have also been described. Mitochondrial cytopathies can result from mitochondrial or nuclear DNA mutations. Early recognition of defects in the coenzyme Q10 (CoQ10) biosynthesis is important, as patients with primary CoQ10 deficiency may be responsive to treatment with oral CoQ10 supplementation, in contrast to most mitochondrial diseases. A literature search was conducted to investigate kidney i
SUBMITTER: Schijvens AM
PROVIDER: S-EPMC7710892 | biostudies-literature | 2020 Dec
REPOSITORIES: biostudies-literature
ACCESS DATA